REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

MEDIRLAB Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: MEDIRLAB Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Medirlab is a medical and biological technology company. With a team specializing in R&D projects and small series product production, the company has recently entered the mass product market with the development of the Magic magnetic distal targeting device. Medirlab offers high added value products in medicine and infrared technology.

Headquarters
Amerikai ut 98. Fsz. 7. ajto
Budapest; Budapest; Postal Code: 1145

Contact Details: Purchase the MEDIRLAB Kft. report to view the information.

Website: http://www.medirlab.hu

Basic Information
Total Employees:
Purchase the MEDIRLAB Kft. report to view the information.
Outstanding Shares:
Purchase the MEDIRLAB Kft. report to view the information.
Registered Capital:
Purchase the MEDIRLAB Kft. report to view the information.
Incorporation Date:
March 19, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after MEDIRLAB Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
320.21%▲
Total operating revenue
312.06%▲
Operating profit (EBIT)
775.66%▲
EBITDA
215.69%▲
Net Profit (Loss) for the Period
2072.04%▲
Total assets
-27.65%▼
Total equity
23.04%▲
Operating Profit Margin (ROS)
4.25%▲
Net Profit Margin
4.93%▲
Return on Equity (ROE)
17.67%▲
Quick Ratio
0.45%▲
Cash Ratio
-0.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo